PPH
VanEck Pharmaceutical ETF
PPH
VanEck Pharmaceutical ETF
-
NAV$88.93
as of April 03, 2025 -
YTD RETURNS3.03%
as of April 03, 2025 -
Total Net Assets$648.14M
as of April 03, 2025 -
Total Expense Ratio0.36%
-
Inception Date12/20/2011
Fund Description
VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
Overview
Fund Highlights
- Highly Liquid Companies
Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume
- Industry Leaders
Index methodology favors the largest companies in the industry
- Global Scope
Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation
Performance
Fees
Holdings
Portfolio
Sector Weightings (%) as at 03/31/2025
-
Sector
% of Net Assets -
Health Care
99.60 -
Other/Cash
0.40
Country Weightings (%) as at 03/31/2025
-
Country
% of Net Assets -
United States
62.41 -
United Kingdom
13.91 -
Switzerland
5.14 -
France
4.81 -
Denmark
4.65 -
Japan
4.49 -
Israel
4.20 -
Other/Cash
0.40